Cargando…

Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma

We developed a nanovector with double targeting properties for efficiently delivering the tumor suppressor gene RASSF1A specifically into hepatocellular carcinoma (HCC) cells by preparing galactosylated-carboxymethyl chitosan-magnetic iron oxide nanoparticles (Gal-CMCS-Fe(3)O(4)-NPs). After conjugat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Wan-Jiang, Feng, Ying, Wang, Fei, Guo, Yi-Bing, Li, Peng, Wang, Lei, Liu, Yi-Fei, Wang, Zhi-Wei, Yang, Yu-Min, Mao, Qin-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768135/ https://www.ncbi.nlm.nih.gov/pubmed/26915683 http://dx.doi.org/10.1038/srep22149

Ejemplares similares

RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma
por: Wang, Fei, et al.
Publicado: (2015)

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma
por: Pranatharthiharan, Sandhya, et al.
Publicado: (2017)

Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
por: Nair, Anroop B., et al.
Publicado: (2019)

Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma
por: Yousef, Shaimaa, et al.
Publicado: (2018)

Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

Erratum to: Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery
por: Quan, Guilan, et al.
Publicado: (2015)

Asialoglycoprotein Receptor-Targeted Superparamagnetic Perfluorooctylbromide Nanoparticles
por: Li, Yang, et al.
Publicado: (2021)

In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor
por: Sun, Rensong, et al.
Publicado: (2021)

The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells
por: Trerè, D, et al.
Publicado: (1999)

Triantennary GalNAc-Functionalized Multi-Responsive Mesoporous Silica Nanoparticles for Drug Delivery Targeted at Asialoglycoprotein Receptor
por: Cordeiro, Rosemeyre, et al.
Publicado: (2022)

A Drug Delivery Strategy: Binding Enkephalin to Asialoglycoprotein Receptor by Enzymatic Galactosylation
por: Christie, Michelle P., et al.
Publicado: (2014)

RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma
por: Li, Jian, et al.
Publicado: (2022)

Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation
por: Li, Wenjiao, et al.
Publicado: (2018)

The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
por: Djos, Anna, et al.
Publicado: (2012)

Monensin inhibits intracellular dissociation of asialoglycoproteins from their receptor
Publicado: (1983)

Distribution of an asialoglycoprotein receptor on rat hepatocyte cell surface
Publicado: (1982)

Immunocytochemical localization of the receptor for asialoglycoprotein in rat liver cells
Publicado: (1982)

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
por: Ahn, Green, et al.
Publicado: (2021)

RASSF6; the Putative Tumor Suppressor of the RASSF Family
por: Iwasa, Hiroaki, et al.
Publicado: (2015)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells
Publicado: (1984)

RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker
por: Jin, Yongshuai, et al.
Publicado: (2015)

The RASSF1 Gene and the Opposing Effects of the RASSF1A and RASSF1C Isoforms on Cell Proliferation and Apoptosis
por: Reeves, Mark E., et al.
Publicado: (2013)

Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line
por: Guhagarkar, Swati A., et al.
Publicado: (2011)

Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma
por: Calvisi, Diego F., et al.
Publicado: (2012)

Detection of Circulating Tumor Cells in Hepatocellular Carcinoma Using Antibodies against Asialoglycoprotein Receptor, Carbamoyl Phosphate Synthetase 1 and Pan-Cytokeratin
por: Li, Jun, et al.
Publicado: (2014)

Ligand- and weak base-induced redistribution of asialoglycoprotein receptors in hepatoma cells
Publicado: (1987)

Three-Dimensional Models of the Oligomeric Human Asialoglycoprotein Receptor (ASGP-R)
por: Massarelli, Ilaria, et al.
Publicado: (2010)

Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity
por: Roggenbuck, Dirk, et al.
Publicado: (2012)

Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein Receptor
por: Scharner, Juergen, et al.
Publicado: (2019)

RASSF Family Proteins
por: Clark, Geoffrey J., et al.
Publicado: (2012)

Predictive value of the serum RASSF10 promoter methylation status in gastric cancer
por: Hu, Yilin, et al.
Publicado: (2019)

Polymeric nanoparticles for dual-targeted theranostic gene delivery to hepatocellular carcinoma
por: Vaughan, Hannah J., et al.
Publicado: (2022)

Two pathways for the degradation of the H2 subunit of the asialoglycoprotein receptor in the endoplasmic reticulum
Publicado: (1993)

Magnetic Graphene Oxide for Dual Targeted Delivery of Doxorubicin and Photothermal Therapy
por: Lu, Yu-Jen, et al.
Publicado: (2018)

TET1 inhibits cell proliferation by inducing RASSF5 expression
por: Li, Bo-Tai, et al.
Publicado: (2017)

RASSF1 Polymorphisms in Cancer
por: Gordon, Marilyn, et al.
Publicado: (2012)

Circulating Hypermethylated RASSF1A as a Molecular Biomarker for Diagnosis of Hepatocellular Carcinoma
por: Mansour, Lamiaa A, et al.
Publicado: (2017)

Prostate-Specific Membrane Antigen and Esterase Dual Responsive Camptothecin–Oligopeptide Self-Assembled Nanoparticles for Efficient Anticancer Drug Delivery
por: Xu, Bing, et al.
Publicado: (2021)

Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment
por: Hu, Jian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jl396qqdms6mga521lk71s8e88